Does Weed Thin Blood? What Science Says

If you take a blood thinner, or you are about to have surgery, the question of whether weed thins blood is not idle curiosity — it is a safety question. The short version is reassuring and worrying at the same time: cannabis is not a blood thinner, but it can still change how your blood clots and how your medication works.

The short answer: No — weed does not thin blood in the way prescribed blood thinners do, and no doctor would ever prescribe it for that purpose. But THC has been shown to reduce platelet activity in animal studies, and both THC and CBD can slow the liver enzymes that clear warfarin, which can push blood-clotting readings (INR) above the safe range. If you take any blood thinner, talk to the doctor who prescribed it before using cannabis.

This article explains published research. It is not medical advice, and it does not replace a conversation with your own doctor or pharmacist.

What does “thinning blood” actually mean?

“Blood thinner” is an everyday phrase for two different groups of medicines, and the distinction matters here.

Anticoagulants slow down the clotting process itself. Warfarin is the classic example; newer drugs in this group include apixaban (Eliquis) and rivaroxaban (Xarelto). Antiplatelet drugs work differently: they stop platelets — the tiny cell fragments that rush to plug a cut — from clumping together. Aspirin and clopidogrel (Plavix) belong to this group.

Cannabis belongs to neither group. It is not licensed, prescribed, or recognised anywhere as an anticoagulant or an antiplatelet drug, and its effects on clotting are far weaker and far less predictable than a real blood thinner. That is the first thing to get straight, because a surprising amount of online content implies weed could stand in for medication. It cannot.

What cannabis does do is subtler: it nudges parts of the clotting system and, more importantly, it interferes with the liver enzymes that clear some blood-thinning medicines from the body. Those two effects are where the real risk sits.

Does weed affect blood clotting at all?

Yes, to a degree — but the evidence comes mostly from animals, not people, and the effect is modest.

The clearest study so far was published in 2022 by Reitsma and colleagues in the American Journal of Physiology – Cell Physiology. The team gave ten rhesus macaques (seven females, three males) a daily edible containing THC, increasing the dose over several months to levels in line with Colorado’s medical cannabis recommendations, then compared blood samples taken before and after the trial.

They found that chronic THC reduced platelet adhesion, aggregation, and granule secretion in response to several triggers that normally make platelets clump. It also lowered production of thromboxane, a lipid involved in clotting. In plain terms, the platelets became less reactive — one step in clot formation was dampened.

But the same study found something equally important: THC did not change clotting times. The blood still clotted on schedule in laboratory tests. So while THC can make platelets less responsive, that did not translate into measurably thinner blood in the animals studied.

There are obvious limits to what this tells us about people. Ten monkeys is a small sample, the doses were controlled edibles rather than smoked cannabis, and animal results do not always carry over to humans. No randomised trial in people has tested whether cannabis changes clotting times, and until one exists, the honest answer is that weed has a real but small and poorly understood effect on platelets — not a blood-thinning effect you could rely on, or one you should count on being harmless.

Can cannabis interact with blood thinners like warfarin?

This is where the evidence gets serious, and it is the main reason doctors worry about the combination.

Warfarin is cleared from the body mainly by a liver enzyme called CYP2C9. THC and CBD both inhibit that enzyme. When the enzyme is slowed down, warfarin clears more slowly, builds up in the blood, and thins the blood more than the prescribed dose was meant to. The result shows up on a blood test as a raised INR (International Normalised Ratio) — the measure of how long blood takes to clot. For most people on warfarin, the target INR sits between 2 and 3; above that range, the risk of bruising and bleeding climbs.

The human evidence is a collection of case reports rather than a large trial, but the pattern is consistent. The best-known case was reported by Grayson and colleagues in 2018 in Epilepsy & Behavior Case Reports: a 44-year-old man with a mechanical heart valve who had been stable on 7.5 mg of warfarin a day, with an INR steady between 2.0 and 2.6 for at least six months. After he started pharmaceutical-grade CBD (Epidiolex) for epilepsy and the dose was increased step by step, his INR rose in a non-linear way, reaching as high as 6.86 at one point. His warfarin dose eventually had to be cut by about 30% to bring his INR back into range. He had no bleeding complications, but only because his INR was being monitored and his dose adjusted.

He is not an isolated case. A systematic review of cannabinoid drug interactions published in 2024 in Frontiers in Pharmacology found that warfarin was among the most frequently reported interactions, with bleeding risk listed as a common adverse outcome. Other case reports describe similar INR spikes after people started smoking cannabis or taking medical cannabis by mouth, and in several cases the warfarin dose had to be reduced by roughly a fifth to a third.

Two things make warfarin especially unforgiving here. First, it has a narrow therapeutic window: the gap between a dose that works and a dose that causes harm is small, so even a modest rise in blood levels matters. Second, the interaction is invisible without a blood test — you cannot feel your INR rising. The warning signs that it has gone too far are easy bruising, nosebleeds, bleeding gums, blood in urine or stool, and cuts that keep bleeding.

If you take warfarin and start, stop, or change how much cannabis you use, your INR should be checked. That is the consistent advice across the case reports and reviews — not to stop either drug on your own, but to make sure the interaction is caught by monitoring.

Does CBD thin blood, and what about other blood thinners?

CBD deserves its own answer, because it behaves differently from THC in one important way — and because many people assume a CBD oil is safer than smoked weed. On clotting, it is not obviously safer.

The Grayson case above involved CBD, not THC: pharmaceutical CBD raised the patient’s INR enough to need a 30% warfarin cut. CBD is also cleared through liver enzymes (mainly CYP2C19 and CYP3A4), and it inhibits them, which is how it interferes with warfarin clearance. So how CBD makes you feel may be gentler than THC, but its interaction with blood thinners follows the same liver-enzyme route.

CBD also raises a different concern with clopidogrel (Plavix). Clopidogrel is a prodrug: it only works after CYP2C19 converts it into its active form. Because CBD inhibits CYP2C19, it can reduce how much active clopidogrel your body produces, which could make the drug less effective and raise the risk of a clot — the opposite problem from warfarin. This was flagged in a 2020 review by Antoniou and colleagues in the Canadian Medical Association Journal, and the prescribing information for Epidiolex carries the same warning. The evidence is largely from laboratory studies and modelling rather than patients having strokes, so it is a theoretical risk rather than a proven one — but for someone who has just had a stent fitted, it is not a risk to take lightly.

For the newer anticoagulants — apixaban, rivaroxaban, dabigatran, and edoxaban, collectively called DOACs — there is almost no published evidence either way. A 2023 systematic review found no published cases of interactions between cannabis and these drugs, which sounds reassuring until you notice the reason: nobody has studied it. These drugs are also cleared partly through CYP3A4, an enzyme CBD can inhibit, so a pharmacological basis for an interaction exists even though no cases have been reported. Absence of evidence is not evidence of absence.

One practical point: interaction risk rises with dose. Reviews suggest clinically noticeable CBD interactions generally start at around 300 mg a day — far above a typical shop-bought dose, but well within the range of prescription CBD. And because CBD stays in your system for days after you take it, the interaction does not switch off the morning after you stop.

Does weed raise the risk of heart attack or stroke?

The clotting question has a bigger cousin: does cannabis change cardiovascular risk overall? A large 2024 study suggests the answer is yes, and in the wrong direction.

Jeffers and colleagues, writing in the Journal of the American Heart Association, analysed survey data from 434,104 adults aged 18 to 74 in the United States, collected between 2016 and 2020. After adjusting for tobacco use and other risk factors, daily cannabis users had 25% higher odds of reporting a heart attack and 42% higher odds of reporting a stroke than non-users. The risk rose with frequency: the more days per month someone used cannabis, the higher the odds. Crucially, the same pattern held among people who had never smoked tobacco, so the finding cannot be dismissed as a side effect of cigarette smoking.

That study has real limits. It was observational and cross-sectional, the cannabis use and the heart attacks were self-reported, and it captured each person at a single point in time — so it shows an association, not proof that cannabis caused the events. THC is also known to raise heart rate and blood pressure shortly after use, and to increase the heart’s demand for oxygen, which offers a plausible mechanism, but a mechanism is not proof either.

Still, for anyone taking a blood thinner because they have already had a heart attack, a stroke, or a clot, the finding matters. The drug is prescribed to reduce exactly the kind of event that daily cannabis use was associated with more of. That is worth a conversation with the prescribing doctor, not a decision made alone.

Prescribed blood thinners (e.g. warfarin, apixaban, clopidogrel) Cannabis (THC / CBD)
Purpose Prevent clots, strokes, and heart attacks Not a clot treatment; no medical use for thinning blood
Effect on platelets Strong, measured, and dose-controlled (antiplatelets) or clotting factors suppressed (anticoagulants) THC reduced platelet aggregation in a 2022 monkey study, but clotting times did not change
Effect on clotting time (INR) Warfarin is dosed to hold INR at 2–3 and monitored with blood tests No direct effect shown; but THC/CBD can raise INR indirectly by slowing warfarin clearance
Predictability Known dose–response, monitored and adjustable Unpredictable — varies with dose, product, and liver enzymes
Main risk Bleeding if overdosed; clotting if underdosed Raised bleeding risk when mixed with warfarin; possibly weaker clopidogrel; higher heart attack and stroke odds with daily use
Evidence quality Large randomised trials Animal studies, case reports, and observational surveys — no human trials on clotting

Should you stop using weed before surgery?

Yes — or at minimum, tell your surgical team exactly what you use, how much, how often, and when you last used it. That is the consistent message from anaesthesia guidance, and it matters more than any single stopping interval.

The first US guideline on cannabis and surgery, published in 2023 by the American Society of Regional Anesthesia and Pain Medicine (Shah et al., Regional Anesthesia and Pain Medicine), recommends that every patient due for anaesthesia be screened for cannabis use — product type, route, amount, frequency, and time of last use — and that elective surgery be delayed for at least two hours after smoking cannabis, because the cardiovascular risk is highest in the first couple of hours. It also recommends postponing elective surgery when a patient is acutely intoxicated and unable to make decisions. The American Society of Anesthesiologists advises against smoking on the day of surgery and notes that use the day before may still carry risk, especially for frequent users. The American College of Surgeons takes a more conservative line, advising no marijuana products in the 72 hours before general anaesthesia.

These numbers are not contradictory so much as layered: two hours is a minimum after smoking, 72 hours is a cautious target, and the right interval for any individual depends on the product, the dose, and the procedure. Edibles and oils have no agreed stopping interval at all, because the evidence is thinner. What every source agrees on is disclosure — cannabis can change how much anaesthetic you need, irritate the airway when smoked, and affect pain control and nausea afterwards, and the anaesthetist can only plan for what they know about.

A meta-analysis presented at the ANESTHESIOLOGY 2026 meeting (Nader et al.) underlines why disclosure matters: pooling five studies with 44,312 surgical patients, the authors found cannabis use was associated with a 46% higher risk of heart attack during or shortly after surgery — and, unexpectedly, a 22% lower risk of venous blood clots. The authors themselves cautioned that the lower clot risk does not prove cannabis protects against clots. These are conference findings, not yet peer-reviewed, so treat them as an early signal rather than settled fact — but the signal points the same way as the rest of the evidence: cannabis and surgery is a conversation to have, not a detail to leave out.

One warning that applies beyond surgery: do not stop a prescribed blood thinner to make room for cannabis, and do not stop prescribed cannabis medicine abruptly without guidance either. Either change can be dangerous, and both belong in a conversation with your doctor.

The bottom line

Weed does not thin blood. It is not a blood thinner, it cannot replace one, and the one solid animal study found it changed platelet behaviour without changing clotting times. But “not a blood thinner” is not the same as “no effect on bleeding”. THC dampens platelet activity, both THC and CBD can slow the liver enzymes that clear warfarin — pushing INR up and bleeding risk with it — and CBD may blunt clopidogrel by blocking the enzyme that activates it. Daily use is also associated with higher odds of heart attack and stroke.

None of that means everyone who uses cannabis and takes a blood thinner will come to harm. It means the combination needs monitoring, honest disclosure to your doctors, and a respect for how thin the evidence still is. If you are on warfarin, a DOAC, or an antiplatelet drug, the safest next step is a short conversation with the clinician who prescribed it — ideally before you change anything about your cannabis use. If you are heading for surgery, tell the anaesthetist. And if you ever notice unusual bruising, nosebleeds, bleeding gums, or blood in your urine or stool while using both, seek medical help promptly rather than waiting to see if it settles.

For a sense of how cannabis affects the body more broadly, see our guides on whether you can smoke too much weed and how CBD makes you feel.

Frequently asked questions

Does weed thin blood?

No. Cannabis is not a recognised blood thinner and is not prescribed to prevent clots. THC has been shown to reduce platelet activity in a 2022 study of rhesus macaques, but it did not change clotting times, and no trial in people has shown a blood-thinning effect.

Can you smoke weed on blood thinners?

You should talk to the doctor who prescribed your blood thinner first. Cannabis can interact with warfarin by slowing the liver enzyme that clears it, which can raise your INR and bleeding risk. The same caution applies to CBD products, and there is almost no published evidence on cannabis with newer blood thinners such as apixaban or rivaroxaban.

Does CBD thin blood?

CBD is not a blood thinner either. But CBD inhibits liver enzymes (CYP2C19 and CYP3A4) that clear several blood-thinning drugs. In one published case, pharmaceutical CBD raised a warfarin patient’s INR so much that his warfarin dose had to be cut by about 30%. CBD may also reduce the effectiveness of clopidogrel, which needs CYP2C19 to become active.

Does weed affect INR levels?

Weed itself has not been shown to change INR directly, but it can raise INR indirectly when taken with warfarin, because THC and CBD slow the CYP2C9 enzyme that breaks warfarin down. Several case reports describe INR spikes after people started cannabis or CBD, with warfarin doses then needing to be reduced by roughly a fifth to a third. If you use cannabis and take warfarin, get your INR checked after any change in use.

Should I stop weed before surgery?

Discuss it with your surgical team rather than deciding alone. Current guidance recommends delaying elective surgery for at least two hours after smoking cannabis, and the American College of Surgeons advises avoiding marijuana products for 72 hours before general anaesthesia. Above all, tell your anaesthetist what you use, how much, and when you last used it — cannabis can affect anaesthesia, breathing, and pain control.

Sources

  1. Reitsma SE, Lakshmanan HHS, Johnson J, et al. Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in nonhuman primates reduces systemic platelet activity and function. American Journal of Physiology – Cell Physiology, 2022;322(3):C370–C381. https://pubmed.ncbi.nlm.nih.gov/35080922/
  2. Grayson L, Vines B, Nichol K, Szaflarski JP. An interaction between warfarin and cannabidiol, a case report. Epilepsy & Behavior Case Reports, 2018;9:10–11. https://pmc.ncbi.nlm.nih.gov/articles/PMC5789126/
  3. Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of cannabis use with cardiovascular outcomes among US adults. Journal of the American Heart Association, 2024;13:e030178. https://www.ahajournals.org/doi/10.1161/JAHA.123.030178

Also cited in the text: Antoniou T et al., cannabinoids and clopidogrel, Canadian Medical Association Journal, 2020; Shah S et al., ASRA Pain Medicine consensus guideline on perioperative cannabis, Regional Anesthesia and Pain Medicine, 2023; Nader ND et al., cannabis use and perioperative outcomes, presented at ANESTHESIOLOGY 2026 (conference findings, not yet peer-reviewed).

Disclaimer: This article is for general information only and is not medical advice. Cannabis can interact with prescription medicines, including blood thinners. Always speak to your doctor or pharmacist before starting, stopping, or changing cannabis use or any prescribed medication.

Published: 14 November 2026. Last updated: 14 November 2026.

Leave a Reply

Your email address will not be published. Required fields are marked *